Literature DB >> 24627299

Effects of a diet rich in n-3 polyunsaturated fatty acids on hepatic lipogenesis and beta-oxidation in mice.

Thereza C Lonzetti Bargut1, Eliete D C Frantz, Carlos A Mandarim-de-Lacerda, Marcia Barbosa Aguila.   

Abstract

Here, we investigate whether a diet rich in fish oil can lead to the development of hepatic alterations associated with non-alcoholic fatty liver disease (NAFLD). To achieve this goal, we provided, for 8 weeks, four different diets to 3-month-old C57BL/6 mice: (a) standard-chow diet (SC; 40 g soybean oil/kg diet, 10 % of the total energy content from lipids), (b) fish oil diet (FO; 4 g soybean oil and 36 g fish oil/kg diet, 10 % of the total energy content from lipids), (c) high-fat diet (HF; 40 g soybean oil and 238 g lard/kg diet, 50 % of the total energy content from lipids), and (d) high-fish oil diet (HFO; 40 g soybean oil and 238 g fish oil/kg diet, 50 % of the total energy content from lipids). Biochemical analyses, stereology, western-blotting and RT-qPCR were used. In the HF group, we found evidence of obesity, metabolic syndrome, and liver damage, along with hypertriglyceridemia, hepatic insulin resistance, and steatosis. On the other hand, the HFO group did not present these alterations and remained similar to the controls. The changes observed in the animals fed the HF diet were accompanied by an increase in hepatic lipogenesis and a decrease in beta-oxidation; meanwhile, in the HFO group, the opposite results were found, that is, reduced lipogenesis and elevated beta-oxidation, were most likely responsible for the prevention of deleterious hepatic alterations and liver damage. In conclusion, a diet rich in fish oil has beneficial effects on hepatic insulin resistance, lipogenesis and beta-oxidation and prevents hepatic tissue from liver damage and NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627299     DOI: 10.1007/s11745-014-3892-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  59 in total

1.  Mechanisms of action of (n-3) fatty acids.

Authors:  Philip C Calder
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

2.  Three dissimilar high fat diets differentially regulate lipid and glucose metabolism in obesity-resistant Slc:Wistar/ST rats.

Authors:  Yoko Hashimoto; Kazuyo Yamada; Hiromi Tsushima; Daisuke Miyazawa; Mayumi Mori; Koji Nishio; Takeshi Ohkubo; Hidehiko Hibino; Naoki Ohara; Harumi Okuyama
Journal:  Lipids       Date:  2013-06-27       Impact factor: 1.880

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 4.  The role of adipose tissue in mediating the beneficial effects of dietary fish oil.

Authors:  Michael J Puglisi; Alyssa H Hasty; Viswanathan Saraswathi
Journal:  J Nutr Biochem       Date:  2010-12-09       Impact factor: 6.048

5.  Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Authors:  T Hayek; Y Ito; N Azrolan; R B Verdery; K Aalto-Setälä; A Walsh; J L Breslow
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 6.  N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.

Authors:  Donald B Jump
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

7.  Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.

Authors:  L Spadaro; O Magliocco; D Spampinato; S Piro; C Oliveri; C Alagona; G Papa; A M Rabuazzo; F Purrello
Journal:  Dig Liver Dis       Date:  2007-12-04       Impact factor: 4.088

8.  N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury.

Authors:  Jessica Zúñiga; Milena Cancino; Fernando Medina; Patricia Varela; Romina Vargas; Gladys Tapia; Luis A Videla; Virginia Fernández
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

9.  Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.

Authors:  Barbara D Pachikian; Ahmed Essaghir; Jean-Baptiste Demoulin; Audrey M Neyrinck; Emilie Catry; Fabienne C De Backer; Nicolas Dejeans; Evelyne M Dewulf; Florence M Sohet; Laurence Portois; Louise Deldicque; Olivier Molendi-Coste; Isabelle A Leclercq; Marc Francaux; Yvon A Carpentier; Fabienne Foufelle; Giulio G Muccioli; Patrice D Cani; Nathalie M Delzenne
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

Authors:  Stanley M H Chan; Ruo-Qiong Sun; Xiao-Yi Zeng; Zi-Heng Choong; Hao Wang; Matthew J Watt; Ji-Ming Ye
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

View more
  19 in total

Review 1.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

2.  Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.

Authors:  Karen Triff; Mathew W McLean; Evelyn Callaway; Jennifer Goldsby; Ivan Ivanov; Robert S Chapkin
Journal:  Int J Cancer       Date:  2018-05-10       Impact factor: 7.396

3.  Okara, a soybean by-product, prevents high fat diet-induced obesity and improves serum lipid profiles in C57BL/6J mice.

Authors:  Hyun-Suk Kim; Ok-Kyeong Yu; Moon-Sun Byun; Youn-Soo Cha
Journal:  Food Sci Biotechnol       Date:  2016-04-30       Impact factor: 2.391

4.  Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.

Authors:  Vanessa Souza-Mello
Journal:  World J Hepatol       Date:  2015-05-18

5.  Mice fed fish oil diet and upregulation of brown adipose tissue thermogenic markers.

Authors:  Thereza Cristina Lonzetti Bargut; Anna Carolina Alves Gomes Silva-e-Silva; Vanessa Souza-Mello; Carlos Alberto Mandarim-de-Lacerda; Marcia Barbosa Aguila
Journal:  Eur J Nutr       Date:  2015-01-23       Impact factor: 5.614

Review 6.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

7.  High Dietary Selenium Intake Alters Lipid Metabolism and Protein Synthesis in Liver and Muscle of Pigs.

Authors:  Zeping Zhao; Matthew Barcus; Jonggun Kim; Krystal L Lum; Courtney Mills; Xin Gen Lei
Journal:  J Nutr       Date:  2016-07-27       Impact factor: 4.798

8.  Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.

Authors:  L M Laiglesia; S Lorente-Cebrián; L Martínez-Fernández; N Sáinz; P L Prieto-Hontoria; M A Burrell; C M Rodríguez-Ortigosa; J A Martínez; M J Moreno-Aliaga
Journal:  Int J Obes (Lond)       Date:  2017-09-12       Impact factor: 5.095

9.  Morphoquantitative analysis of the Ileum of C57BL/6 mice (Mus musculus) fed with a high-fat diet.

Authors:  Javiera Navarrete; Bélgica Vásquez; Mariano Del Sol
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.

Authors:  Marion Valle; Patricia L Mitchell; Geneviève Pilon; Philippe St-Pierre; Thibault Varin; Denis Richard; Marie-Claude Vohl; Hélène Jacques; Edgar Delvin; Emile Levy; Claudia Gagnon; Laurent Bazinet; André Marette
Journal:  J Nutr       Date:  2021-05-11       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.